Zevra Therapeutics, Inc. (ZVRA)
8.70
-0.23
(-2.58%)
USD |
NASDAQ |
Jan 20, 10:11
Zevra Therapeutics Market Cap: 489.79M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 319.36M |
| Verastem, Inc. | 503.51M |
| ADMA Biologics, Inc. | 4.089B |
| Akebia Therapeutics, Inc. | 348.96M |
| NovaBay Pharmaceuticals, Inc. | 1.123B |
Market Cap Related Metrics
| PE Ratio | 13.79 |
| PS Ratio | 5.632 |
| Price to Book Value | 3.678 |
| Price | 8.70 |
| Earnings Yield | 7.25% |
| Normalized PE Ratio | 6.084 |